IPSOS

Ipsos shares fell about 9.9% to €37.52 after the immediate appointment of Kelly Beaver as the new CEO. Jean-Laurent Poitou is leaving the company shortly after his appointment in August 2025 and after the presentation of the “Horizons” strategy plan, raising doubts about continuity in execution. Beaver, with Ipsos since 2011 and most recently head of the global healthcare business, is due to address markets for the first time on 14 September 2026. The price decline followed a prior strong rally that had lifted the stock from around €32.80 in early July to a 52-week high of €42.98 on 29 July; Q2 results showed revenues of €615.2m and organic growth of 3.0%. » More on de.investing.com

Ipsos reported a 2.4% revenue decline to €555m in Q1, with currency effects (-5.4%) masking underlying momentum and a 3.0% increase on a constant-currency basis. Management unveiled the AI-driven transformation strategy 'Horizons', announced leadership appointments and showcased products such as the GMS platform, influencer analytics and digital consumer twins. The order book showed an organic recovery (+1%) and Ipsos confirmed its full-year guidance of 2–3% organic growth and an operating result at the 2025 level, citing currency risks, Middle East uncertainties and the divestment of the Russia business as the main uncertainties. » More on de.investing.com

Ipsos SA reported revenue of EUR 555m for Q1 2026 (-2.4% year-on-year) with organic growth of -1.4% and negative currency effects of -5.4%. The acquisition contribution was +4.3%, while the Ipsos Digital platform grew double-digit; there were also strong businesses in China and contract wins in the public sector in the US, France and the UK. The company confirms its full-year guidance for organic growth of 2–3% and an operating result at the level of 12.3%. The stock rose 3.88% to EUR 39.67 after the earnings call. » More on de.investing.com